Valuation : Intrasense

Market Cap 12.06M 13.98M 11.34M 10.33M 19.43M 1.33B 19.54M 134M 52.2M 675M 52.49M 51.35M 2.24B P/E 2023
-5.16x
P/E 2024 -2.14x
Enterprise Value 12.53M 14.53M 11.79M 10.74M 20.2M 1.38B 20.31M 139M 54.25M 702M 54.56M 53.37M 2.33B EV / Sales 2023
4.76x
EV / Sales 2024 5.62x
Free-Float
44.56%
Yield 2023 *
-
Yield 2024 -
1 day-3.15%
1 week-16.89%
Current month-3.15%
1 month+9.82%
3 months+3.36%
6 months+1.23%
Current year+7.42%
1 week 0.25
Extreme 0.246
0.3
1 month 0.2
Extreme 0.201
0.47
Current year 0.19
Extreme 0.19
0.47
1 year 0.19
Extreme 0.19
0.47
3 years 0.19
Extreme 0.19
0.55
5 years 0.19
Extreme 0.19
0.69
10 years 0.19
Extreme 0.186
2.43
Manager TitleAgeSince
Chief Executive Officer - 2024-08-27
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Director/Board Member 65 2019-03-14
Director/Board Member - 2020-10-07
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-3.15%-16.89%-16.04%-52.69% 15.54M
-2.69%-4.40%+21.87%+7.77% 228B
-3.10%-4.19%+0.54%-22.09% 150B
-2.02%-0.70%-21.98%+18.96% 133B
-0.46%-3.57%-54.43%-10.33% 70B
-0.01%-0.14%+11.56%+18.80% 52.31B
+0.43%-1.01%-17.61%-14.19% 50.59B
-2.36%-3.13%+19.31%+22.98% 43.3B
-2.12%-2.08%+34.47%+44.42% 40.74B
-3.64%-2.21%-15.72%+45.34% 34.63B
Average -1.62%-2.80%-3.80%+5.90% 80.3B
Weighted average by Cap. -1.60%-1.59%-0.32%+6.10%

Financials

2023 2024
Net sales 3.3M 3.83M 3.11M 2.83M 5.33M 364M 5.35M 36.75M 14.31M 185M 14.39M 14.07M 613M 2.25M 2.6M 2.11M 1.92M 3.62M 247M 3.64M 24.98M 9.72M 126M 9.78M 9.56M 417M
Net income -3.58M -4.15M -3.37M -3.07M -5.77M -394M -5.8M -39.8M -15.49M -200M -15.58M -15.24M -664M -5.66M -6.56M -5.32M -4.85M -9.11M -622M -9.16M -62.89M -24.48M -316M -24.61M -24.08M -1.05B
Net Debt -3.06M -3.55M -2.88M -2.62M -4.94M -337M -4.96M -34.06M -13.26M -171M -13.33M -13.04M -568M 475K 551K 447K 407K 765K 52.26M 770K 5.28M 2.06M 26.58M 2.07M 2.02M 88.15M
Logo Intrasense
Founded in 2004, Intrasense designs medical imaging software solutions natively enriched by artificial intelligence algorithms. Intrasense Product portfolio includes Myrian®, an advanced radiology visualization platform featuring cutting-edge clinical tools, which optimizes and simplifies the interpretation of all types of images. DUOncoTM, a range of expert AI algorithms for oncology, offers AI for the detection of pancreatic lesions, focal liver lesions, and the world's first CE-marked AI dedicated to bone lesions. Liflow®, a dedicated oncology monitoring solution integrating multi-organ AI, optimizes the longitudinal monitoring of cancer patients. By combining clinical expertise and operational performance, Intrasense provides healthcare professionals with high medical value tools, facilitating analysis, diagnosis and patient management.
Employees
76
Date Price Change Volume
26-09-01 €0.2460 -3.15% 92,624
26-08-31 €0.2540 -7.30% 227,718
26-08-28 €0.2740 -3.18% 151,707
26-08-27 €0.2830 -3.74% 160,697
26-08-26 €0.2940 -0.68% 409,373
  1. Stock Market
  2. Stocks
  3. ALINS Stock